Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 158

    1.

    The treatment of lupus nephritis: revisiting Galen.

    Lewis EJ.

    Ann Intern Med. 2001 Aug 21;135(4):296-8. No abstract available. PMID: 11511144 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Long-term outcome in lupus nephritis.

    Spiera RF, Homel P, Spiera H.

    Ann Intern Med. 2002 Sep 17;137(6):545-6; author reply 545-6. No abstract available. PMID: 12230360 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Kidney disease in patients with lupus who are treated with potent drugs that suppress the immune system.

    [No authors listed]

    Ann Intern Med. 2001 Aug 21;135(4):S-29. No abstract available. PMID: 11529202 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Treatment of proliferative lupus nephritis: a changing landscape.

    Adu D.

    Kidney Int. 2006 Aug;70(4):616-8.PMID: 16900218 [PubMed - indexed for MEDLINE]Related articles

    5.

    Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.

    Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

    Kidney Int. 2006 Aug;70(4):732-42. Epub 2006 Jul 5.PMID: 16820790 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Treatment of nephritis in systemic lupus erythematodes]

    Ligtenberg G, Derksen RH, Berden JH.

    Ned Tijdschr Geneeskd. 1996 Sep 28;140(39):1941-4. Review. Dutch. No abstract available. PMID: 8927179 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

    Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT.

    Ann Intern Med. 2001 Aug 21;135(4):248-57.PMID: 11511139 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.

    Gourley MF, Austin HA 3rd, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD.

    Ann Intern Med. 1996 Oct 1;125(7):549-57.PMID: 8815753 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Induction therapy for active lupus nephritis: mycophenolate mofetil versus cyclophosphamide.

    Burchardi C, Schlöndorff D.

    Nat Clin Pract Nephrol. 2006 Jun;2(6):314-5. No abstract available. PMID: 16932452 [PubMed - indexed for MEDLINE]Related articles

    10.

    Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.

    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus.

    Arthritis Rheum. 2007 Mar;56(3):924-37.PMID: 17328070 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Remission from lupus nephritis resistant to cyclophosphamide after additional treatment with cyclosporin A.

    Ferrario L, Bellone M, Bozzolo E, Baldissera E, Sabbadini MG.

    Rheumatology (Oxford). 2000 Feb;39(2):218-220. No abstract available. PMID: 10725082 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.

    Contreras G, Tozman E, Nahar N, Metz D.

    Lupus. 2005;14 Suppl 1:s33-8.PMID: 15803929 [PubMed - indexed for MEDLINE]Related articles

    13.

    Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children.

    Fujinaga S, Kaneko K, Ohtomo Y, Murakami H, Takada M, Akashi S, Hira M, Yamashiro Y.

    Pediatr Nephrol. 2005 Oct;20(10):1500-3. Epub 2005 Jul 15.PMID: 16021476 [PubMed - indexed for MEDLINE]Related articles

    14.

    Mycophenolate mofetil for lupus nephritis.

    McCune WJ.

    N Engl J Med. 2005 Nov 24;353(21):2282-4. No abstract available. PMID: 16306526 [PubMed - indexed for MEDLINE]Related articles

    15.

    Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

    Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB.

    N Engl J Med. 2005 Nov 24;353(21):2219-28.PMID: 16306519 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Treatment of lupus nephritis: art or science?

    Endre Z.

    Intern Med J. 2001 Jul;31(5):264-6. No abstract available. PMID: 11512596 [PubMed - indexed for MEDLINE]Related articles

    17.

    [Interdisciplinary consensus to management of lupus nephritis in Germany]

    de Groot K.

    Z Rheumatol. 2007 Dec;66(8):724, 726. German. PMID: 17965864 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Results of treatment of lupus nephritis in children. Own experience]

    Kwinta-Rybicka J, Sancewicz-Pach K.

    Pol Merkur Lekarski. 2000 Apr;8(46):232-4. Polish. PMID: 10897625 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.

    Karassa FB, Isenberg DA.

    N Engl J Med. 2001 Feb 1;344(5):382-3. No abstract available. Erratum in: N Engl J Med 2001 Apr 12;344(15):1176. PMID: 11195799 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data